1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60. doi: 10.1016/S0140-6736(12)61766-8 23245609
2. World Health Organization. A global brief on hypertension—silent killer, global public health crisis. Geneva: World Health Organization; 2013 [cited 2020 May 29]. https://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/.
3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97. doi: 10.1056/NEJMra050100 16079372
4. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47(3):345–51. doi: 10.1161/01.HYP.0000200702.76436.4b 16432045
5. Hanley J, Ure J, Pagliari C, Sheikh A, McKinstry B. Experiences of patients and professionals participating in the HITS home blood pressure telemonitoring trial: a qualitative study. BMJ open. 2013;3(5):e002671. doi: 10.1136/bmjopen-2013-002671 23793649
6. Public Health Scotland. GP consulations/Practice Team Information (PTI) statistics. Edinburgh: Public Health Scotland; 2020 [cited 2020 May 29]. https://www.isdscotland.org/Health-Topics/General-Practice/GP-Consultations/.
7. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142–61. doi: 10.1161/01.HYP.0000150859.47929.8e 15611362
8. NHS Digital. General and personal medical services, England. March 2018: provisional experimental statistics. Leeds: NHS Digital; 2018 [cited 2020 May 29]. https://files.digital.nhs.uk/63/5DF8AA/General%20and%20Personal%20Medical%20Services%20-%20Provisional%20March%202018.pdf.
9. NHS Digital. Appointments in general practice, October 2018 [PAS]. Leeds: NHS Digital; 2018 [cited 2019 May 25]. https://digital.nhs.uk/data-and-information/publications/statistical/appointments-in-general-practice/oct-2018.
10. National Health Service. The NHS long term plan. London: National Health Service; 2019 [cited 2020 May 29]. https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf.
11. Scottish Government. Scotland’s digital health and care strategy: enabling, connecting and empowering. Edinburgh: Scottish Government; 2018 [cited 2020 May 29]. https://www.gov.scot/publications/scotlands-digital-health-care-strategy-enabling-connecting-empowering/.
12. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57(1):29–38. doi: 10.1161/HYPERTENSIONAHA.110.160911 21115879
13. Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389. doi: 10.1371/journal.pmed.1002389 28926573
14. Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FD, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol. 2014;21(12):1517–30. doi: 10.1177/2047487313501886 23990660
15. Monahan M, Jowett S, Nickless A, Franssen M, Grant S, Greenfield S, et al. Cost-effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4). Hypertension. 2019;73(6):1231–9. doi: 10.1161/HYPERTENSIONAHA.118.12415 31067190
16. McKinstry B, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ 2013;346:f3030. doi: 10.1136/bmj.f3030 23709583
17. Shahaj O, Denneny D, Schwappach A, Pearce G, Epiphaniou E, Parke HL, et al. Supporting self-management for people with hypertension: a meta-review of quantitative and qualitative systematic reviews. J Hypertens. 2019;37(2):264–79. doi: 10.1097/HJH.0000000000001867 30020240
18. Scott Kruse C, Karem P, Shifflett K, Vegi L, Ravi K, Brooks M. Evaluating barriers to adopting telemedicine worldwide: a systematic review. J Telemed Telecare. 2018;24(1):4–12. doi: 10.1177/1357633X16674087 29320966
19. Taylor J, Coates E, Brewster L, Mountain G, Wessels B, Hawley MS. Examining the use of telehealth in community nursing: identifying the factors affecting frontline staff acceptance and telehealth adoption. J Adv Nurs. 2015;71(2):326–37. doi: 10.1111/jan.12480 25069605
20. Davidson E, Simpson CR, Demiris G, Sheikh A, McKinstry B. Integrating telehealth care-generated data with the family practice electronic medical record: qualitative exploration of the views of primary care staff. Interact J Med Res. 2013;2(2):e29. doi: 10.2196/ijmr.2820 24280631
21. Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ. 2017;356:i6795. doi: 10.1136/bmj.i6795 28264797
22. Florence. Manchester: Florence; 2020 [cited 2020 May 29]. http://www.getflorence.co.uk.
23. Paterson M, McAulay A, McKinstry B. Integrating third-party telehealth records with the general practice electronic medical record system: a solution. J Innov Health Inform. 2017;24(4):915. doi: 10.14236/jhi.v24i4.915 29334351
24. Docman. Castleford (UK): Docman; 2020 [cited 2020 May 28]. http://www.docman.com/.
25. Scottish Government. Technology enabled care. Edinburgh: Scottish Government; 2014 [cited 2020 Jun 1]. https://news.gov.scot/news/technology-enabled-care.
26. Hanley J, Pinnock H, Paterson M, McKinstry B. Implementing telemonitoring in primary care: learning from a large qualitative dataset gathered during a series of studies. BMC Fam Pract. 2018;19(1):118. doi: 10.1186/s12875-018-0814-6 30021535
27. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. doi: 10.1186/1748-5908-6-42 21513547
28. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82(4):581–629. doi: 10.1111/j.0887-378X.2004.00325.x 15595944
29. Miech EJ, Rattray NA, Flanagan ME, Damschroder L, Schmid AA, Damush TM. Inside help: an integrative review of champions in healthcare-related implementation. SAGE Open Med. 2018;6:2050312118773261. doi: 10.1177/2050312118773261 29796266
30. Scottish Government. The Scottish Index of Multiple Deprivation. Edinburgh: Scottish Government; 2016 [cited 2020 May 29]. https://www2.gov.scot/Topics/Statistics/SIMD.
31. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. Clinical guideline [CG127]. London: National Institute for Health and Care Excellence; 2011.
32. WHO Collaborating Centre for Drug Statistics Methodology. International language for drug utilization research—ATC/DDD. Olso: WHO Collaborating Centre for Drug Statistics Methodology; 2020 [cited 2020 May 29]. https://www.whocc.no/.
33. Hanley J, Fairbrother P, Krishan A, McCloughan L, Padfield P, Paterson M, et al. Mixed methods feasibility study for a trial of blood pressure telemonitoring for people who have had stroke/transient ischaemic attack (TIA). Trials. 2015;16:117. doi: 10.1186/s13063-015-0628-y 25873155
34. McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163–72. doi: 10.1016/S0140-6736(10)60964-6 20619448
35. McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–59. doi: 10.1016/S0140-6736(18)30309-X 29499873
36. Wild SH, Hanley J, Lewis SC, McKnight JA, McCloughan LB, Padfield PL, et al. Supported telemonitoring and glycemic control in people with type 2 diabetes: the Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial. PLoS Med. 2016;13(7):e1002098. doi: 10.1371/journal.pmed.1002098 27458809
37. Parker RA, Paterson M, Padfield P, Pinnock H, Hanley J, Hammersley VS, et al. Are self-reported telemonitored blood pressure readings affected by end-digit preference: a prospective cohort study in Scotland. BMJ Open. 2018;8(1):e019431. doi: 10.1136/bmjopen-2017-019431 29391369
38. Greiver M, Kalia S, Voruganti T, Aliarzadeh B, Moineddin R, Hinton W, et al. Trends in end digit preference for blood pressure and associations with cardiovascular outcomes in Canadian and UK primary care: a retrospective observational study. BMJ Open. 2019;9(1):e024970. doi: 10.1136/bmjopen-2018-024970 30679298
39. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. doi: 10.1136/bmj.b1665 19454737